Proteomics International Laboratories Ltd (ASX: PIQ) has released new performance data from its majority-owned subsidiary, OxiDx Pty Ltd, in collaboration with The University of Western Australia. The findings were presented at the Australian Physiological Society (AuPS) Annual Scientific Meeting in Sydney, Australia, confirming that Thoroughbred racehorses competing without oxidative stress were significantly more likely to perform at higher levels.

Proteomics International Laboratories Ltd (ASX: PIQ) has received $2.2 million in R&D tax incentive refunds for the 2024–25 financial year, reinforcing its financial position as the Company advances multiple diagnostic products towards commercialisation. Based in Perth, Western Australia, the Company continues to develop next-generation diagnostic tools built on its proprietary Promarker® technology platform, with applications across chronic disease detection, women’s health,

Proteomics International Laboratories Ltd (ASX: PIQ) has been granted ISO 15189 certification for its Australian laboratory operations – a key milestone that cements its role as a leader in precision diagnostics. This certification validates the company’s systems, processes, and quality management, ensuring accurate and dependable clinical results.

Proteomics International Laboratories (ASX: PIQ) has unveiled new results for its PromarkerEso blood test, a patented, first-in-class diagnostic that delivers a simple and scalable pathway for early detection. With clinical validation showing high accuracy in identifying early-stage EAC, PromarkerEso may well change the standard of care in managing this difficult disease. With patents already granted in Europe, China, and Australia—and other territories pending.

Proteomics International Laboratories Ltd (ASX: PIQ), a recognised pioneer in precision diagnostics, has announced a significant development for the Western Australian scientific and medical landscape: a $6 million funding boost to expand the WA Proteomics Facility. This strategic investment will be delivered over three years, with contributions from the WA State Government, Bioplatforms Australia, the University of Western Australia (UWA), and Proteomics International itself

Let’s be honest: endometriosis has long been one of the most underdiagnosed and misunderstood medical conditions in women's health. A silent disruptor, it causes pain, fertility issues, and decades-long suffering, often without a name. Until now, the only path to a diagnosis was invasive laparoscopic surgery, usually after seven years of misdiagnosis. That’s not a system built for healing. But what if we could change that narrative with a simple blood test?